These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16807130)

  • 1. Minimization method for balancing continuous prognostic variables between treatment and control groups using Kullback-Leibler divergence.
    Endo A; Nagatani F; Hamada C; Yoshimura I
    Contemp Clin Trials; 2006 Oct; 27(5):420-31. PubMed ID: 16807130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
    Mollié A; Hill C
    Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estimation of distributions and the minimum relative entropy principle.
    Mühlenbein H; Höns R
    Evol Comput; 2005; 13(1):1-27. PubMed ID: 15901422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic balancing randomization in controlled clinical trials.
    Heritier S; Gebski V; Pillai A
    Stat Med; 2005 Dec; 24(24):3729-41. PubMed ID: 16320277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kullback-Leibler divergence for evaluating bioequivalence.
    Dragalin V; Fedorov V; Patterson S; Jones B
    Stat Med; 2003 Mar; 22(6):913-30. PubMed ID: 12627409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of simulation to compare the performance of minimization with stratified blocked randomization.
    Toorawa R; Adena M; Donovan M; Jones S; Conlon J
    Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of pharmacokinetic sampling schedules in clinical phase I trials: a use of Kullback-Leibler information.
    Yafune A; Ishiguro M
    Stat Med; 2001 Apr; 20(7):1033-49. PubMed ID: 11276034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomization by minimization for unbalanced treatment allocation.
    Han B; Enas NH; McEntegart D
    Stat Med; 2009 Nov; 28(27):3329-46. PubMed ID: 19739238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial.
    Weir CJ; Lees KR
    Stat Med; 2003 Mar; 22(5):705-26. PubMed ID: 12587101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups.
    Kawaguchi A; Koch GG; Ramaswamy R
    Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exact, distribution free confidence intervals for late effects in censored matched pairs.
    Daniel SR
    Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal design for dose response using beta distributed responses.
    Wu Y; Fedorov VV; Propert KJ
    J Biopharm Stat; 2005; 15(5):753-71. PubMed ID: 16078383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rank-Minimization for balanced assignment of subjects in clinical trials.
    Stigsby B; Taves DR
    Contemp Clin Trials; 2010 Mar; 31(2):147-50. PubMed ID: 20004741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-parametric methods for comparing multiple treatment groups to a control group, based on incomplete non-decreasing repeated measurements.
    Davis CS
    Stat Med; 1996 Dec; 15(23):2509-21. PubMed ID: 8961460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative interactions in multifactor studies.
    Russek-Cohen E; Simon RM
    Biometrics; 1993 Jun; 49(2):467-77. PubMed ID: 8369382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.